Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018
Chonnam Medical Journal · 2019 · 55 (1) · 47
DOI: 10.4068/cmj.2019.55.1.47 ↗Kurz gefasst
Leitlinie in der Zeitschrift Chonnam Medical Journal, 2019. Verfasst von Tae-Ok Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: COPD
Abstract (Originalsprache)
The guidelines for chronic obstructive pulmonary disease (COPD) treatment are important for the management of the disease. However, studies regarding the treatment adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines have been scarce in Korea. Therefore, to examine the adherence to the GOLD guidelines, we examined the patterns of prescribed medication in COPD patients from 2011 to 2018. Patients were classified as having been appropriately and inappropriately treated (overtreatment or undertreatment) for the GOLD group. Appropriate medical therapy was defined as using the first choice or alternative choice drug recommended in the GOLD guidelines. Inappropriate therapy was classified as overtreatment or undertreatment in accordance with the categorization in the GOLD guidelines. According to treatment of 2011 GOLD guidelines, there was inappropriate treatment in 52.3% in group A, 47.3% in group B, 56.3% in group C, and 17.8% in group D. According to treatment of 2017 GOLD guidelines, there was inappropriate treatment in 66.7% in group A, 45.3% in group B, 14.3% in group C, and 24.0% in group D. The common type of inappropriate COPD treatment is overtreatment, with inhaled corticosteroid (ICS) containing regimens. In conclusions, adherence to the GOLD guideline by the pulmonologist in clinical practice is still low in Korea. Therefore, we need better strategies to both optimize the use of the guidelines and adhere to the guidelines as well.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.
- Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea.
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and the Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, S…
- Division of Pulmonary Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical School, Anyang, Korea.
Zitieren
APA
Kim, T. O., Shin, H. J., Kim, Y. I., Rhee, C. K., Lee, W. Y., Lim, S. Y., Ra, S. W., Jung, K. S., Yoo, K. H., Park, S. J., & Lim, S. C. (2019). Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018. Chonnam Medical Journal, 55(1), 47. https://doi.org/10.4068/cmj.2019.55.1.47
Vancouver
Kim TO, Shin HJ, Kim YI, Rhee CK, Lee WY, Lim SY, et al. Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018. Chonnam Medical Journal. 2019;55(1):47. doi:10.4068/cmj.2019.55.1.47
BibTeX
@article{Kim2019,
author = {Kim, Tae-Ok and Shin, Hong-Joon and Kim, Yu-Il and Rhee, Chin-Kook and Lee, Won-Yeon and Lim, Seong-Yong and Ra, Seung-Won and Jung, Ki-Suck and Yoo, Kwang-Ha and Park, Seoung-Ju and Lim, Sung-Chul},
title = {Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018},
journal = {Chonnam Medical Journal},
year = {2019},
volume = {55},
number = {1},
pages = {47},
doi = {10.4068/cmj.2019.55.1.47}
}
EUVIMED